Venus Remedies Ltd share price logo

Venus Remedies Share Price

NSE: VENUSREM

BSE: 526953

Small Cap

Healthcare Sector

₹868.25

+12.85

(+1.50%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Venus Remedies Stock Performance

as on March 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹860.95
    ₹898.15
    downward going graph

    0.84%

    Downside

    3.44%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹277.95
    ₹944.75
    downward going graph

    67.99%

    Downside

    8.81%

    Upside

    downward going graph

Venus Remedies share price movements today

Previous Close
₹855.40
Open
₹860.95
Volume
37.74K
Upper Circuit
₹898.15
Lower Circuit
₹812.65
Day's Low - High
₹860.95 - ₹898.15
52 Week Low - High
₹277.95 - ₹944.75

Venus Remedies Historical Returns

1 Month Return
+ 16.18 %
3 Month Return
+ 7.82 %
1 Year Return
+ 191.75 %
3 Year Return
+ 411.79 %
5 Year Return
+ 205.45 %

Venus Remedies Fundamentals

as on March 20, 2026 at 4:01 pm IST

Market Cap

₹1,160.59 Cr

Return on Equity (ROE)

8.1

PE Ratio (TTM)

15.21

Return on capital employed (ROCE)

11.75

Industry PE ratio

40.5

Beta (LTM)

0.75

P/B Ratio

0.68

Dividend Yield

0

PEG Ratio

0.49

Quarterly Earnings Growth YOY

30.51

EPS (TTM)

33.9

Sector

Pharmaceuticals

Book Value

419.65

Technical Analysis

Bullish

View Technical Analysis

Venus Remedies Stock Valuation

as on March 20, 2026 at 4:01 pm IST

Venus Remedies in the last 5 years

  • Overview

  • Trends

Lowest (-45.34x)

September 23, 2020

Today (15.21x)

March 20, 2026

Industry (40.50x)

March 20, 2026

Highest (21.70x)

December 28, 2023

LowHigh

Today’s Price to Earnings Ratio: 15.21x

Venus Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Venus Remedies Ltd image
Venus Remedies Ltd
NA1,160.5941.09%0.5045647
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA10.8545.85%0.00-121
Lasa Supergenerics Ltd image
Lasa Supergenerics Ltd
NA35.72-17.76%0.00-15142
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA2,026.882.15%0.571181,811
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
BUY1,202.5833.45%0.5082623
See all

Venus Remedies Stock’s Investor Sentiment and Interest

Search interest for Venus Remedies Ltd Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:60% versus previous 30 day period

Venus Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
155.64
95.15
167.72
143.42
195.16
108.61
170.1
176.52
194.97
137.18
192.75
180.26
Other Income
3.41
2.26
3.05
2.35
3.92
1.59
7.93
12.28
6.76
3.41
1.71
2.52
Total Income
159.05
97.41
170.77
145.77
199.08
110.2
178.03
188.8
201.73
140.59
194.46
182.78
Expenses
131.03
84.75
149.93
131.38
175.69
97.35
162.53
158.5
165.97
121.8
161.79
142.74
Operating Profit
24.61
10.4
17.79
12.04
19.47
11.26
7.57
18.02
29
15.38
30.96
37.52
Operating Profit Margin %
15.81%
10.93%
10.61%
8.39%
9.98%
10.37%
4.45%
10.21%
14.87%
11.21%
16.06%
20.81%
Profit Before Interest, Tax and Depreciation
28.02
12.66
20.84
14.39
23.39
12.85
15.5
30.3
35.76
18.79
32.67
40.04
Interest
-
0.06
0.06
0.07
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
Depreciation
8.29
7.55
6.44
6.54
5.91
5.98
6.41
5.41
4.71
6.18
6.17
6.56
Profit Before Tax
19.73
5.05
14.34
7.78
17.46
6.85
9.07
24.88
31.04
12.6
26.49
33.47
Tax Paid
8.67
3.87
4.4
0.93
6.95
5.63
5.56
5.28
10.04
3
6.36
7.89
Profit After Tax
11.06
1.18
9.94
6.85
10.51
1.22
3.51
19.6
21
9.6
20.13
25.58
Total Net profit including share of profit / Loss from associate company
11.06
1.18
9.94
6.85
10.51
1.22
3.51
19.6
21
9.6
20.13
25.58
EPS
8.27
0.88
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
Actual EPS
8.27
0.88
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
Adjusted EPS
8.27
0.88
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14
Diluted EPS
8.27
0.88
7.44
5.13
7.86
0.92
2.63
14.66
15.71
7.18
15.06
19.14

Venus Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
400.04
372.41
321.89
341.46
548.12
600.18
555.51
601.45
652.89
Other Income
2.27
2.26
6.09
5.31
43.07
8.31
10.32
11.58
25.86
Total Income
402.31
374.67
327.99
346.77
591.2
608.49
565.83
613.03
678.75
Expenses
349.32
332.94
298.33
309.49
494.35
538.07
495.49
541.85
584.35
Operating Profit
50.72
39.47
23.56
31.97
53.77
62.11
60.02
59.6
68.54
Operating Profit Margin %
12.68%
10.6%
7.32%
9.36%
9.81%
10.35%
10.8%
9.91%
10.5%
Profit Before Interest, Tax and Depreciation
52.99
41.73
29.66
37.29
96.85
70.42
70.34
71.18
94.4
Interest
34.37
35.43
25.41
13.31
13.02
0.48
0.12
0.09
0.07
Depreciation
40.26
33.83
33.98
32.01
35.28
33.53
32.3
26.45
22.51
Profit Before Tax
-21.64
-27.53
-29.73
-8.03
48.55
36.41
37.92
44.64
71.82
Tax Paid
-4.56
3.16
-1.15
1.96
-13.21
-4.32
11.36
16.16
26.5
Profit After Tax
-17.08
-30.69
-28.58
-10
61.77
40.73
26.56
28.48
45.32
Total Net profit including share of profit / Loss from associate company
-17.08
-30.69
-28.58
-10
61.77
40.73
26.56
28.48
45.32
EPS
-14.88
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
Actual EPS
-14.88
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
Adjusted EPS
-14.88
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9
Diluted EPS
-14.88
-24.87
-23.15
-8.1
50.04
30.86
19.88
21.31
33.9

Venus Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
46.88
58.93
31.19
45.33
77.6
131.84
41.1
36.63
37.29
86.44
Cash Flow from Investing Activities
3.39
-22.82
20.25
-1.41
-4.69
57.34
-17.24
-58.11
-8.46
-76.86
Cash Flow from Financing Activities
-46.35
-44.12
-39.23
-35.17
-73
-162.24
-9.48
-0.57
-1.08
-1.02
Net Cash Flow
3.46
-3.51
0.42
-1.17
-0.09
26.94
14.38
-22.04
27.74
8.57

Venus Remedies Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
41.76%
DII
0.15%
0.15%
0.15%
0.15%
0.15%
0.15%
0%
0%
0.11%
0.75%
1.03%
FII
0%
1.03%
1.59%
1.48%
1.06%
1.18%
1.11%
1.34%
2.24%
1.86%
2.26%
Public
57.11%
57.07%
56.5%
56.61%
57.03%
56.91%
57.13%
56.9%
55.89%
55.63%
54.96%
Total Outstanding Shares
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
1,33,66,988
Total Shareholders
20,498
19,267
19,560
19,913
19,614
19,557
19,771
19,982
19,307
17,725
18,606

Venus Remedies Corporate Actions

View detailed summary of the earnings and dividend history of Venus Remedies.

  • Venus Remedies Ltd Earnings Results

    Venus Remedies Ltd’s net profit jumped 30.51% since last year same period to ₹25.58Cr in the Q3 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated 27.07% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Venus Remedies Ltd Dividends May,2013

    In the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 0.69%.

    Read More about Dividends

Insights on Venus Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, VENUSREM stock has moved up by 16.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.86% to 2.26% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 9.6 Cr → 25.58 Cr (in ₹), with an average increase of 36.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 41.76% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 55.63% to 54.96% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 194.46 Cr → 182.78 Cr (in ₹), with an average decrease of 6.0% per quarter

About Venus Remedies Ltd

Established in 1989, Venus Remedies Limited is a family managed company based out of Panchkula district at Haryana, India. The company specializes in Intravenous/Intramuscular injectible forms and Eye/Ear/Nose drops and has been GMP certified by the WHOGeneva. In 2001, Venus Remedies had tied up with a top Australian company to set-up a Cephalosporin project at a cost of Rs 4.5 crores. The company is also manufacturing injections for leading firms like Panacea Biotech and Morepan Laboratories among others. Over the years, Venus Remedies has been able to successfully introduce 13 new products in their Animal Health division, which include names like Megox3000, Paroxin3000, Pisa3000, MicalRonid and Dexolyte, to name a few.

Revenue: ₹180.26Cr as on December 2025 (Q3 FY26)
Net Profit: ₹25.58Cr as on December 2025 (Q3 FY26)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
OrganisationVenus Remedies Ltd
HeadquartersPanchkula
IndustryPharmaceuticals
CEOPawan Chaudhary
E-voting on sharesClick here to vote

FAQs

What is Venus Remedies share price today?

Venus Remedies share price today stands at ₹868.25 as on at the close of the market. Venus Remedies share today touched a day high of ₹898.15 and a low of ₹860.95.

What is the 52 week high and 52 week low range for Venus Remedies share?

Venus Remedies touched a 52 week high of ₹944.75 and a 52 week low of ₹277.95. Venus Remedies share price today i.e. is closed at ₹868.25, which is -8.10% down from its 52 week high and 212.38% up from its 52 week low.

What is Venus Remedies's market capitalisation today?

Venus Remedies market capitalisation is ₹1,160.59 Cr as on .

How to buy Venus Remedies shares?

To buy Venus Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VENUSREM or Venus Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Venus Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Venus Remedies trading volume today?

Venus Remedies trading volume is 37.74K as on . This means that 37.74K shares of Venus Remedies were bought and sold on the stock market during today's trading session.